Capa, Wilsion P.

HRN: 28-62-08  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/01/2026
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
03/01/2026
03/08/2026
IV
487.5mg
Q24h
Sepsis
Checking Initial Appropriateness 

 Indication:  Empiric    Type of Infection:  Urinary TractIntra-abdominal    Compliance to guidelines: Compliant To Guidelines